S. Betty Yan

Merestinib (LY2801653) inhibits neurotrophic receptor kinase (NTRK) and suppresses growth of NTRK fusion bearing tumors

D. Timm, R. Walgren, P. Ebert, 2018, Oncotarget.

High mobility group protein, hmg‐1, contains insignificant glycosyl modification

W. Scovell, Y. Chao, S. Betty Yan, 1994, Protein science : a publication of the Protein Society.